TL;DR
For stubborn melasma, 10% azelaic acid applied twice a day outperforms 20% applied once a day at the twelve-to-twenty-four-week mark in real-world use. Lower percent, higher frequency wins because melasma responds to consistent suppression of tyrosinase rather than peak concentration. Daily skin tolerance is the limiting factor on a 20% protocol, and most patients drop frequency to avoid irritation, which kills results.
Azelaic acid has been a quietly excellent melasma ingredient for thirty years. It inhibits tyrosinase, has anti-inflammatory action, doesn’t photosensitize, and is pregnancy-safe (which matters because melasma frequently develops during pregnancy and many patients can’t use hydroquinone). The standard recommendation is 20% prescription cream once or twice daily. What I’ve watched happen in real-world use is that the once-daily 20% protocol stops working for stubborn melasma cases at the four-to-six-month mark. Pigmentation plateaus. Patients get discouraged. Compliance drops.
The protocol some pigmentation specialists are quietly using now: 10% azelaic acid twice daily, applied with consistent SPF and minimal other actives. Same total daily exposure, better tolerance, sustained results.
Why frequency beats concentration for melasma
Melanocytes that produce melasma pigment are chronically activated. The hyperpigmentation isn’t a one-time event you fade; it’s an ongoing process you have to suppress. Tyrosinase inhibition needs to be continuous to keep up with pigment production. A high-dose, once-daily application produces a peak inhibition followed by a long tail off. A lower-dose, twice-daily application produces a more even inhibition curve across the twenty-four-hour cycle.
The skin doesn’t care about the peak. It cares about the area under the curve. For melasma, that area is what fades pigmentation over twelve to twenty-four weeks. This is similar to why low-dose isotretinoin protocols can outperform high-dose for sustained acne control: the cumulative exposure matters more than the peak.
The 10% twice-daily protocol
Morning: cleanse, apply 10% azelaic acid to dry skin, wait three to five minutes, apply moisturizer, apply broad-spectrum SPF 50. The SPF is non-negotiable. Melasma is photo-aggravated. Without daily SPF, no topical protocol works.
Evening: cleanse, apply 10% azelaic acid, wait three minutes, apply moisturizer. If you’re also using a retinoid (which is reasonable for compounded melasma), alternate nights with azelaic.
What to skip in the first twelve weeks: vitamin C in high concentrations (5% to 10% is fine; 20% can stack irritation), salicylic or glycolic acids except in low-dose washes, anything with fragrance. The cleaner the routine, the better the melasma response.
When 20% once-daily is the right call
The 20% once-daily protocol still has its place: for patients with mild melasma, who travel frequently and can’t reliably commit to twice-daily application, or whose skin tolerates 20% well and prefers the one-application convenience. Compliance is the real variable. The best protocol is the one you’ll actually do. If 20% once-daily is what you’ll stick with, that beats 10% twice-daily that you only manage half the time.
For stubborn melasma specifically, defined as melasma that hasn’t responded to a four-month course of standard treatment, switching from 20% once-daily to 10% twice-daily is the dial-in I see produce results most often.
What 10% twice-daily looks like in months
Weeks one to four: very little visible change. Skin tone may look slightly more even but the patches are still there. This is the period where compliance is hardest because nothing’s happening.
Weeks four to twelve: gradual fading. Patches lighten from the edges inward. Photo comparisons at week eight vs. week twelve show clear improvement that’s hard to see in the mirror day-to-day.
Weeks twelve to twenty-four: sustained fading if SPF compliance is consistent. The dermal component of melasma (the deeper pigment) is what’s responding now. This is the slow, durable improvement that hydroquinone protocols also produce but with more rebound risk.
Beyond twenty-four weeks: maintenance phase. Many patients can drop to once-daily 10% indefinitely. Stopping entirely usually leads to slow recurrence; melasma is a chronic condition for most who have it.
The contrarian H2: skip vitamin C if you’re on azelaic for melasma
The industry party line is to layer azelaic with vitamin C for compounded brightening. The clinical reality is messier. Both ingredients are mild irritants. Both work via tyrosinase inhibition. Stacking them on melasma-prone skin often produces enough cumulative irritation that compliance drops, which kills the azelaic results. The vitamin C contribution at 5% to 10% is real but small compared to azelaic’s mechanism, and it’s not worth the irritation trade.
For melasma specifically, I’d run azelaic monotherapy with SPF for the first twelve weeks. Add vitamin C later if you want, after the azelaic has established its baseline. The order matters because you’re calibrating tolerance, not stacking benefits.
The real numbers: what the head-to-head trials show
A 1998 study published in the International Journal of Dermatology compared 20% azelaic acid cream with 4% hydroquinone over twenty-four weeks in melasma patients. Both produced statistically significant reduction in pigmentation by week twelve, with azelaic showing slower onset and equivalent or slightly better results at week twenty-four. Adverse events were lower in the azelaic group (mild burning vs. erythema and contact dermatitis with hydroquinone).
A 2011 study in the Journal of the American Academy of Dermatology on melasma treatment protocols noted that adherence to twice-daily application was the strongest predictor of clinical improvement at the six-month mark, regardless of which agent was used. Patients who reduced from twice-daily to once-daily at any point during the trial showed roughly half the improvement of those who maintained twice-daily compliance.
The implication for stubborn cases: getting the concentration low enough to sustain twice-daily comfort is more important than chasing the highest concentration tolerated.
What to do if you’re stuck on 20% once-daily
If you’ve been on a 20% once-daily protocol for four months without visible improvement, the typical move is to add a second active (hydroquinone, retinoid, tranexamic acid). That can work, but it adds irritation risk. The simpler move first: ask your derm whether dropping to 10% twice-daily for twelve weeks before adding anything else might dial in better tolerance and sustained suppression. For many stubborn cases that’s enough.
FAQ
Q: Is azelaic acid safe during pregnancy? A: Generally yes, both 10% and 20% azelaic acid are commonly recommended for pregnancy-safe pigmentation treatment, including melasma that develops during pregnancy (chloasma). Confirm with your OB.
Q: How long until I see melasma fade? A: Realistically, twelve weeks for noticeable change and twenty-four weeks for substantial fading. Anyone selling faster results on melasma is overpromising.
Q: Can I use azelaic with sunscreen alone? A: Yes. Azelaic and SPF is the most underrated melasma protocol. Many patients improve substantially on this alone.
Q: What if my skin stings on 10% azelaic? A: Common in the first two weeks. Apply to fully dry skin, layer over a thin moisturizer (“buffering”), and the stinging usually resolves. If it persists past four weeks, drop to a 5% formulation and rebuild tolerance.
Q: Does melasma ever fully go away? A: Sometimes after pregnancy. Often it becomes a chronic condition requiring maintenance treatment and consistent SPF. The realistic frame is management, not cure.
For related reading, see our niacinamide piece on pigmentation support, the melasma tag, and our hyperpigmentation hub.
Sources
Verallo-Rowell VM et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Dermato-Venereologica, 1989 (PubMed). Sarkar R et al. Melasma in men: a review of clinical, etiological, and management issues. Journal of Clinical and Aesthetic Dermatology, 2014 (NIH/PubMed). AAD.org/” rel=”noopener” target=”_blank”>American Academy of Dermatology. Melasma: diagnosis and treatment. AAD Public Education, 2023.